Exclusive Content
Shanghai FTZ Lingang Special Area: Semiconductor, AI, and Biomedicine Incentives in 2026
Shanghai's Lingang Special Area offers a 15% CIT rate for 5 years, subsidized housing, and streamlined customs for integrated circuits, AI, and biomedicine companies. Here's the full incentive package.
Hainan Free Trade Port 2026: Independent Customs Regime and What It Means for Foreign Investors
Hainan's independent customs regime is scheduled for full operation by 2027. Here's what the zero-tariff policy, 15% CIT rate, and relaxed capital controls mean for foreign investors.
Equity vs. Cooperative JV in China: Which Structure Fits Your Business Goal?
China offers two JV structures: Equity Joint Venture (EJV) and Cooperative Joint Venture (CJV). Compare profit distribution, governance, and exit flexibility for each in 2026.
Finding a Chinese JV Partner: 4 Vetting Steps Before You Sign
Choosing the wrong Chinese JV partner is the most common reason foreign JVs fail. Here's a 4-step vetting process covering financial health, government relationships, and cultural fit.
Joint Venture in China: 5 Contract Terms Foreign Partners Must Negotiate in 2026
China JV contracts require careful negotiation on 5 key terms: deadlock resolution, IP ownership, technology transfer, exit rights, and non-compete clauses. Here's what to negotiate.
Clinical Trials in China for Foreign Medical Device Companies: 2026 Timeline and Cost
China requires local clinical trial data for most Class II and III medical devices. Here's what foreign manufacturers need to know about timeline, cost, and GCP compliance in 2026.